Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post‐translational modification: a multiple target approach
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.